Danaparoid and platelet count decreased Patient Reports February 12, 2012

Danaparoid Side Effects Report #5049291-7
Danaparoid side effect was reported by a Health Professional from AUSTRALIA on June 29, 2006. Male patient was diagnosed with thrombectomy and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: platelet count decreased, vena cava thrombosis. Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN. Patient died.

Danaparoid Side Effects Report #5135919-X
Danaparoid side effect was reported by a Consumer or non-health professional from ISRAEL on Oct 12, 2006. Female patient, 63 years of age, was diagnosed with heparin-induced thrombocytopenia and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, platelet count decreased, pneumonia , thrombosis. Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN, NOREPINEPHRINE BITARTRATE, OXACILLIN, AMIODARONE. Patient recovered.

Danaparoid Side Effects Report #5139587-2
Danaparoid side effect was reported by a Health Professional from AUSTRALIA on Oct 17, 2006. Male patient, 60 years of age, was diagnosed with heparin-induced thrombocytopenia and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: dialysis device complication, multi-organ failure, platelet count decreased, thrombosis in device. Danaparoid dosage: unknown. During the same period patient was treated with LEPIRUDIN, HEPARIN. Patient died.

Danaparoid Side Effects Report #5042436-4
Danaparoid side effect was reported by a Consumer or non-health professional from FRANCE on June 14, 2006. Female patient, 50 years of age, was diagnosed with heparin-induced thrombocytopenia and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: abdominal haematoma, anaemia, leukopenia, neutropenia, platelet count decreased. Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN, OMEPRAZOLE, PAROXETINE HYDROCHLORIDE, FOLIC ACID, FERROUS SULPHATE. Patient was hospitalized. Patient recovered.


Danaparoid Side Effects Report #5061700-6
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on July 10, 2006. Female patient, 88 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood potassium decreased, blood urea increased, c-reactive protein increased, fibrin d dimer increased, platelet count decreased, prothrombin time prolonged. Danaparoid dosage: unknown. During the same period patient was treated with POLYGLOBIN, PRIMAXIN, DOPAMINE, FLOMOXEF. Patient recovered.

Danaparoid Side Effects Report #4873367-8
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Dec 28, 2005. Female patient, 81 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, hypokalaemia, platelet count decreased, subdural haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with PREDNISOLONE ACETATE OPHTHALMIC, DOPAMINE, FUROSEMIDE, OMEPRAZOLE, GLYCERYL. Patient died.

Danaparoid Side Effects Report #4968091-7
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Mar 27, 2006. Female patient, 81 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, brain oedema, hypokalaemia, melaena, platelet count decreased, subdural haemorrhage, white blood cell count decreased. Danaparoid dosage: unknown. During the same period patient was treated with PREDNISOLONE ACETATE OPHTHALMIC, DOPAMINE, LASIX, OMEPRAZOLE, GLYCEROL, CARBAZOCHROME SULFONATE. Patient died.

Danaparoid Side Effects Report #5020297-7
Danaparoid side effect was reported by a Consumer or non-health professional from ARMENIA on May 24, 2006. Female patient, 81 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, brain oedema, cerebral haemorrhage, gastrointestinal haemorrhage, hypokalaemia, melaena, platelet count decreased, prothrombin time prolonged, subdural haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with PREDNISOLONE ACETATE, DOPAMINE, LASIX, OMEPRAZOLE, GLYCEROL, CARBAZOCHROME SULFONATE. Patient died.

Danaparoid Side Effects Report #5020449-6
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on May 24, 2006. Female patient, 81 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, brain oedema, gastrointestinal haemorrhage, hypokalaemia, melaena, platelet count decreased, prothrombin time prolonged, subdural haemorrhage, white blood cell count decreased. Danaparoid dosage: unknown. During the same period patient was treated with PREDNISOLONE ACETATE, DOPAMINE, LASIX, OMEPRAZOLE, GLYCEROL, CARBAZOCHROME SULFONATE. Patient died.


Danaparoid Side Effects Report #5029101-4
Danaparoid side effect was reported by a Health Professional from JAPAN on June 07, 2006. Male patient, 78 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, anaemia, blood lactate dehydrogenase increased, blood potassium increased, blood urea increased, platelet count decreased, prothrombin time prolonged, subdural haematoma. Danaparoid dosage: unknown. During the same period patient was treated with MENATETRENONE, MAGNESIUM OXIDE, FAMOTIDINE, FUROSEMIDE, ALLOPURINOL. Patient died.

Danaparoid Side Effects Report #5033187-0
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 13, 2006. Male patient, 77 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, disease progression, gastrointestinal haemorrhage, haemorrhage subcutaneous, platelet count decreased, prothrombin time prolonged. Danaparoid dosage: unknown. During the same period patient was treated with MEROPENEM, CIMETIDINE, EPOETIN BETA, HEPARIN. Patient died.

Danaparoid Side Effects Report #5113491-8
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 05, 2006. Male patient, 74 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia postoperative, blood lactate dehydrogenase increased, condition aggravated, hepatic function abnormal, malnutrition, platelet count decreased, postoperative infection, renal impairment. Danaparoid dosage: unknown. During the same period patient was treated with IMIPENEM, ANTITHROMBIN III, IMMUNE GLOBULIN INTRAVENOUS, MENATETRENONE, HYDROCORTISONE PHOSPHATE, GABEXATE MESILATE, CLINDAMYCIN, CIPROFLOXACIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5020454-X
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Apr 04, 2006. Female patient, 56 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood bilirubin increased, condition aggravated, gastric ulcer haemorrhage, haematocrit decreased, haemoglobin decreased, platelet count decreased, protein total decreased, sepsis , white blood cell count decreased. Danaparoid dosage: unknown. During the same period patient was treated with SULPERAZON, FAMOTIDINE, CARBAZOCHROME SULFONATE, TRANEXAMIC ACID, FLURBIPROFEN, NEUPOGEN, METHYLPREDNISOLONE SUCCINATE, ISEPAMICIN SULPHATE. Patient died.

Danaparoid Side Effects Report #5056234-9
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on July 07, 2006. Male patient, 43 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, bacteraemia, diarrhoea, enterocolitis, febrile neutropenia, fibrin degradation products increased, platelet count decreased, prothrombin time prolonged, red blood cell count decreased. Danaparoid dosage: unknown. During the same period patient was treated with PLASMA PROTEIN FRACTION, TRANEXAMIC ACID, ETOPOSIDE, NOVANTRONE, ISEPAMICIN SULPHATE, CEFTAZIDIME, ALLOPURINOL. Patient recovered.


Danaparoid Side Effects Report #5017007-6
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Apr 27, 2006. Male patient, 43 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, bacteraemia, enterocolitis, febrile neutropenia, fibrin degradation products increased, platelet count decreased, prothrombin time prolonged, red blood cell count decreased, white blood cell count decreased. Danaparoid dosage: unknown. During the same period patient was treated with PLASMA PROTEIN FRACTION, TRANEXAMIC ACID, ETOPOSIDE, NOVANTRONE, ISEPAMICIN SULPHATE, CEFTAZIDIME, ALLOPURINOL. Patient recovered.

Danaparoid Side Effects Report #4951228-3
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Mar 10, 2006. Male patient, 41 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, fibrin degradation products increased, platelet count decreased, subarachnoid haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with ENOCITABINE, IDARUBICIN, RAMOSETRON HYDROCHLORIDE. Patient died.

Danaparoid Side Effects Report #4939443-6
Danaparoid side effect was reported by a Consumer or non-health professional from FRANCE on Feb 27, 2006. Female patient, 78 years of age, was treated with Danaparoid. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, haematoma, haemothorax, leukocytosis, multi-organ failure, platelet count decreased, post procedural haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN. Patient was hospitalized. Patient died.

Danaparoid Side Effects Report #4747893-6
Danaparoid side effect was reported by a Consumer or non-health professional from FRANCE on Aug 03, 2005. Male patient, 62 years of age, was treated with Danaparoid. After drug was administered, patient experienced the following side effects: haematoma, hypotension, livedo reticularis, motor dysfunction, oxygen saturation abnormal, pericarditis, platelet count decreased, tachycardia. Danaparoid dosage: unknown. During the same period patient was treated with ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #4975620-6
Danaparoid side effect was reported by a Health Professional from GERMANY on Apr 03, 2006. Male patient, 62 years of age, was treated with Danaparoid. After drug was administered, patient experienced the following side effects: disease recurrence, platelet count decreased, pulmonary embolism , thrombosis. Danaparoid dosage: unknown. During the same period patient was treated with PREDNISONE, AMPHOTERICIN B, NITRENDIPINE. Patient died.


Danaparoid Side Effects Report #5139586-0
Danaparoid side effect was reported by a Consumer or non-health professional from AUSTRALIA on Oct 20, 2006. Female patient, 58 years of age, was treated with Danaparoid. After drug was administered, patient experienced the following side effects: platelet count decreased. Danaparoid dosage: unknown. During the same period patient was treated with METHADONE HYDROCHLORIDE, DARBEPOETIN ALFA, MYCOPHENOLATE MOFETIL, PREDNISOLONE, FLUOXETINE HYDROCHLORIDE, CALCIUM CARBONATE, CALCITRIOL, FOLIC ACID. Patient was hospitalized. Patient recovered.